181 related articles for article (PubMed ID: 32998027)
1. An approach for the extract generation and toxicological assessment of tobacco-free 'modern' oral nicotine pouches.
E B; N E; S B; S S; D S; M T; S M; A B; D B; D T; M G
Food Chem Toxicol; 2020 Nov; 145():111713. PubMed ID: 32998027
[TBL] [Abstract][Full Text] [Related]
2. Multi-endpoint in vitro toxicological assessment of snus and tobacco-free nicotine pouch extracts.
Yu F; Bishop E; Miazzi F; Evans R; Smart D; Breheny D; Thorne D
Mutat Res Genet Toxicol Environ Mutagen; 2024 Apr; 895():503738. PubMed ID: 38575247
[TBL] [Abstract][Full Text] [Related]
3. Enamel staining with e-cigarettes, tobacco heating products and modern oral nicotine products compared with cigarettes and snus: An in vitro study.
Dalrymple A; Bean EJ; Badrock TC; Weidman RA; Thissen J; Coburn S; Murphy J
Am J Dent; 2021 Feb; 34(1):3-9. PubMed ID: 33544982
[TBL] [Abstract][Full Text] [Related]
4. A screening approach for the evaluation of tobacco-free 'modern oral' nicotine products using Real Time Cell Analysis.
East N; Bishop E; Breheny D; Gaca M; Thorne D
Toxicol Rep; 2021; 8():481-488. PubMed ID: 33718000
[TBL] [Abstract][Full Text] [Related]
5. Oral nicotine pouches with an aftertaste? Part 2: in vitro toxicity in human gingival fibroblasts.
Rinaldi S; Pieper E; Schulz T; Zimmermann R; Luch A; Laux P; Mallock-Ohnesorg N
Arch Toxicol; 2023 Sep; 97(9):2343-2356. PubMed ID: 37482550
[TBL] [Abstract][Full Text] [Related]
6. In vitro permeation of nicotine and tobacco specific nitrosamines from smokeless tobacco product extracts in a 3D buccal tissue model.
Keyser BM; Flockton H; Weidman RA; Payne R; Rowe J; Jordan KG
Toxicol Lett; 2024 Feb; 392():36-45. PubMed ID: 38142871
[TBL] [Abstract][Full Text] [Related]
7. Application of ToxTracker for the toxicological assessment of tobacco and nicotine delivery products.
Smart DE; Bozhilova S; Miazzi F; Haswell LE; Gaca MD; Thorne D; Breheny D
Toxicol Lett; 2022 Apr; 358():59-68. PubMed ID: 35065211
[TBL] [Abstract][Full Text] [Related]
8. Multiple endpoint in vitro toxicity assessment of a prototype heated tobacco product indicates substantially reduced effects compared to those of combustible cigarette.
Chapman F; Sticken ET; Wieczorek R; Pour SJ; Dethloff O; Budde J; Rudd K; Mason E; Czekala L; Yu F; Simms L; Nahde T; O'Connell G; Stevenson M
Toxicol In Vitro; 2023 Feb; 86():105510. PubMed ID: 36372310
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of Nicotiana gossei leaves, used in the Australian Aboriginal smokeless tobacco known as pituri or mingkulpa.
Moghbel N; Ryu B; Cabot PJ; Ratsch A; Steadman KJ
Toxicol Lett; 2016 Jul; 254():45-51. PubMed ID: 27178269
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress responses in human bronchial epithelial cells exposed to cigarette smoke and vapor from tobacco- and nicotine-containing products.
Munakata S; Ishimori K; Kitamura N; Ishikawa S; Takanami Y; Ito S
Regul Toxicol Pharmacol; 2018 Nov; 99():122-128. PubMed ID: 30227175
[TBL] [Abstract][Full Text] [Related]
11. Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums.
Azzopardi D; Liu C; Murphy J
Drug Chem Toxicol; 2022 Sep; 45(5):2246-2254. PubMed ID: 34034614
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols.
Misra M; Leverette RD; Cooper BT; Bennett MB; Brown SE
Int J Environ Res Public Health; 2014 Oct; 11(11):11325-47. PubMed ID: 25361047
[TBL] [Abstract][Full Text] [Related]
13. An inter-laboratory in vitro assessment of cigarettes and next generation nicotine delivery products.
Ito S; Taylor M; Mori S; Thorne D; Nishino T; Breheny D; Gaça M; Yoshino K; Proctor C
Toxicol Lett; 2019 Oct; 315():14-22. PubMed ID: 31400404
[TBL] [Abstract][Full Text] [Related]
14. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches.
Mallock N; Schulz T; Malke S; Dreiack N; Laux P; Luch A
Tob Control; 2024 Feb; 33(2):193-199. PubMed ID: 38378209
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tobacco heating product THP1.0. Part 5: In vitro dosimetric and cytotoxic assessment.
Jaunky T; Adamson J; Santopietro S; Terry A; Thorne D; Breheny D; Proctor C; Gaça M
Regul Toxicol Pharmacol; 2018 Mar; 93():52-61. PubMed ID: 28987911
[TBL] [Abstract][Full Text] [Related]
16. Assessment of mouth-level exposure to tobacco constituents in U.S. snus consumers.
Caraway JW; Chen PX
Nicotine Tob Res; 2013 Mar; 15(3):670-7. PubMed ID: 22990227
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
Lunell E; Fagerström K; Hughes J; Pendrill R
Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
[TBL] [Abstract][Full Text] [Related]
18. Screening of different cytotoxicity methods for the assessment of ENDS toxicity relative to tobacco cigarettes.
Caruso M; Emma R; Rust S; Distefano A; Carota G; Pulvirenti R; Polosa R; Li Volti G
Regul Toxicol Pharmacol; 2021 Oct; 125():105018. PubMed ID: 34314750
[TBL] [Abstract][Full Text] [Related]
19. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus).
Alizadehgharib S; Lehrkinder A; Alshabeeb A; Östberg AK; Lingström P
Eur J Oral Sci; 2022 Aug; 130(4):e12885. PubMed ID: 35853092
[TBL] [Abstract][Full Text] [Related]
20. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
